Inflammatory myofibroblastic tumor of the bladder treated with partial cystectomy: Case report

膀胱炎性肌纤维母细胞瘤行部分膀胱切除术治疗:病例报告

阅读:1

Abstract

INTRODUCTION: Inflammatory myofibroblastic tumor (IMT) is a rare form of tumor which is composed of fibroblastic and myofibroblastic spindle cells, with an inflammatory infiltrate of lymphocytes, plasma cells, and eosinophils. IMT may arise from different organs, but it is infrequent in the urinary bladder and usually manifests as haematuria. CASE PRESENTATION: Here we report a 20 years old male patient with no previous history of trauma or surgery presented with gross hematuria and severe anaemia. Further workup with transurethral resection biopsy and immunohistochemistry are supportive of IMT and we did partial cystectomy. Follow up cystoscopy after 3 months showed normal bladder wall. CLINICAL DISCUSSION: An inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumor. It comprises differentiated myofibroblastic spindle cells with numerous plasma cells and/or lymphocyte infiltrate. According to the World Health Organisation (WHO) classification, IMT is a low grade or borderline mesenchymal tumor. The commonest site for IMT is the lung, but it rarely occur in the genitourinary tract. Hematuria is the commonest manifestation of bladder IMT. Transurethral resection of bladder tumor (TURBT) and partial cystectomy are treatment modalities. CONCLUSION: IMT of the bladder is a rare tumor which manifests mainly with hematuria. Although TURBT is the standard treatment for IMT, partial cystectomy has lower recurrence rate.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。